T Helper and B Cell Escape Mutations within the HBc Gene in Patients with Asymptomatic HBV Infection: A Study From the South-Eastern Region of Iran
There are no files associated with this record.
| Title | T Helper and B Cell Escape Mutations within the HBc Gene in Patients with Asymptomatic HBV Infection: A Study From the South-Eastern Region of Iran |
|---|---|
| Author | Assar, Shokrollah; Arababadi, Mohammad Kazemi; Mohit, Maryam; Ahmadabadi, Behzad Nasiri; Pumpens, Paul; Khorramdelazad, Hossein; Hajghani, Masomeh; Assar, Sepideh; Araste, Majid; Nekhei, Zohre; Sendi, Hossein; Kennedy, Derek |
| Journal Name | Clinical Laboratory |
| Year Published | 2012 |
| Place of publication | Germany |
| Publisher | Clinical Laboratory Publications |
| Abstract | Background: Escape mutations potentially allow viruses to avoid detection and clearance by the host immune sys-tem and may represent a mechanism through which infections may persist in some patients. The association of the mutations in the HBcAg gene with Hepatitis B asymptomatic carriers (ASC) has not been studied adequately. The current study was aimed to investigate HBcAg18-27 CTL epitope mutations in ASC patients in the South-Eastern region of Iran. Methods: 100 ASC patients were selected for this study and screened for HLA-A2 using flow cytometry. HBV-DNA was extracted from the HLA-A2 positive patients and the HBc gene was amplified using PCR. Direct double sequencing was performed to analyse mutations in the HBc gene of HBV isolates from patients with ASC. Results: Overall, 25 (25%) of individuals were HLA-A2 positive. Direct double sequencing indicated no mutations in the HBcAg18-27 epitope. However, four mutations within the T helper and three mutations within the B cell epitopes of ASC patients were identified. Conclusions: The lack of mutations within the HBcAg18-27 epitope suggests that the antigenicity of this region is not altered in HBV isolates of our patients and therefore antigen presentation would occur normally to the pa-tient’s immune system through HLA-A2. However, in the course of this study we revealed some novel mutations within the T helper and B cell epitopes that may affect the efficiencies of immune response of ASC patients against these novel HBV epitopes. (Clin. Lab. 2012;58:53-60) |
| Peer Reviewed | Yes |
| Published | Yes |
| Publisher URI | http://www.clin-lab-publications.com/archive/2012-01-01.html |
| Volume | 58 |
| Page from | 53 |
| Page to | 60 |
| ISSN | 1433-6510 |
| Date Accessioned | 2012-02-10 |
| Date Available | 2013-06-05T02:07:50Z |
| Language | en_US |
| Research Centre | Eskitis Institute for Drug Discovery |
| Faculty | Faculty of Science, Environment, Engineering and Technology |
| Subject | Gastroenterology and Hepatology; Medical Genetics (excl Cancer Genetics) |
| URI | http://hdl.handle.net/10072/46900 |
| Publication Type | Journal Articles (Refereed Article) |
| Publication Type Code | c1 |
Please use this identifier to cite this record: http://hdl.handle.net/10072/46900
Griffith University copyright notice
Copyright in individual works within the repository belongs to their authors or publishers. You may make a print or digital copy of a work for your personal non-commercial use. All other rights are reserved, except for fair dealings or other user rights granted by the copyright laws of your country.
Back to top